UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: November 9, 1998
MEDIX RESOURCES, INC
(Exact name of registrant as specified in its charter)
Colorado 000-24768 84-1123311
(State or other jurisdiction (Commission (IRS Employer
of incorporation) (File Number) Identification No.)
7100 East Belleview Ave., Suite 301, Englewood, CO 80111
- ----------------------------------------------------- ----------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 741-4828
None
(Former name or former address, if changes since last report)
Item 5. Other Events
Press release dated November 9, 1998 announcing the initiation of an Internet
based medical communications network product pilot project.
Reg. S-K
Exhibit No. Description Item No.
*99.1 Press release 99
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIX RESOURCES, INC.
Date: November 13, 1998 By:/s/ John P. Yeros
John P. Yeros, President and Chief Executive Officer
Company Contacts:
Medix Resources, Inc. WellPoint Pharmacy Management
John P. Yeros Rhonda Seaton
(303) 741-2074 (818) 703-2566
Cymedix Lynx Corporation
Keith Berman
(805) 203-1133
FOR IMMEDIATE RELEASE
MEDIX RESOURCES AND WELLPOINT PHARMACY MANAGEMENT
INITIATE E-COMMERCE ENTERPRISE WITH CYMEDIX
LYNX INTERNET-BASED PHARMACY MANAGEMENT NETWORKS
Denver, Colorado, November 9, 1998. Medix Resources, Inc. (OTC: MDIX) through
its Cymedix Lynx Internet medical networks division, and WellPoint Pharmacy
Management, (a subsidiary of WellPoint Health Networks (NYSE: WLP) today
announced the initiation of an Internet-based E-commerce pilot project for the
Cymedix-Lynx FRx, the first completely secure patent-pending, Internet-based
medical communications network product.
Initially, certain physicians affiliated with WellPoint Pharmacy Management
clients, on the east and west coasts, will utilize the Internet-based Cymedix
Lynx FRx product under an E-commerce enterprise model, for the management of
patient medication history, formulary compliance, electronic prescription, and
other proprietary WellPoint Pharmacy Management tools. The two companies
envision expansion of the enterprise to additional WellPoint Pharmacy Management
clients covering over 16 million lives.
Cymedix Lynx secure Internet medical networks offer an unmatched solution in the
challenge of moving, sharing and tracking medical data to many sectors of the
evolving healthcare system. Through a novel use of the Internet, Cymedix offers
E-commerce model medical networks without a need for capital investment on the
part of the managed care or medical network provider.
WellPoint Pharmacy Management, a subsidiary of one of the nation's largest
publicly traded managed care companies, is the nation's leading health plan
owned pharmacy benefit management organization, serving over 16 million
patients. Based in California, WellPoint Pharmacy Management offers a broad
spectrum of quality benefit management products and services provided to health
plans nationally.
Denver-based Medix Resources, Inc. through its wholly owned subsidiary Cymedix
Lynx Corporation of Thousand Oaks, California, offers several fully secure
patent-pending Internet medical communications products, using an Internet
commerce business model. The Company's core business also provides skilled
nursing, therapy, rehabilitation and other medical personnel for flexible
staffing in home care and in a broad spectrum of healthcare and educational
facilities.
<PAGE>
***
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: The Statements contained in this release which are not historical facts
contain forward-looking information with respect to plans, projections and/or
future performance of the Company, the occurrence of which involve certain risks
and uncertainties detailed in the Company's Form 10K-SB for 1997 and Form 10-QSB
for its second quarter of 1998 that were filed with the Securities and Exchange
Commission on March 30, 1998 and August 12, 1998. Such information is available
from the SEC or from the Company.
